ask="50.00"
ask_size="100"
average_daily_volume="362273"
bid="40.50"
bid_size="100"
book_value="14.89"
change="+0.10"
change_from_200_day_moving_average="-3.29"
change_from_50_day_moving_average="-0.11"
change_from_52_week_high="-14.41"
change_From_52_week_low="16.22"
change_in_percent="+0.22%"
close="46.57"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="-97.57M"
eps_estimate_current_year="-3.15"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-1.51"
ex_dividend_date="N/A"
float_shares="24414000"
high="49.30"
high_52_weeks="60.98"
last_trade_date="2/24/2017"
last_trade_price="46.57"
last_trade_size="12979"
last_trade_time="4:00pm"
low="45.00"
low_52_weeks="30.35"
market_capitalization="1.28B"
moving_average_200_day="49.86"
moving_average_50_day="46.68"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="45.00"
pe_ratio="N/A"
peg_ratio="0.25"
percent_change_from_200_day_moving_average="-6.60%"
percent_change_from_50_day_moving_average="-0.23%"
percent_change_from_52_week_high="-23.63%"
percent_change_from_52_week_low="+53.44%"
previous_close="46.47"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.12"
price_per_sales="41.54"
revenue="30.69M"
shares_outstanding="27436000"
short_ratio="6.80"
stock_exchange="NMS"
symbol="FPRX"
volume="512306"
weeks_range_52="30.35 - 60.98"
